Fast-spreading Covid variant PJ.2.1: What Indians need to know

A new Covid variant called PJ.2.1 has recently emerged, capturing the attention of health authorities worldwide. This variant, first identified in Canada in May 2026, has since been detected in several countries, such as the US, Singapore, Australia, France, and Spain. A study published in the Journal of Infection in October 2026 examined the characteristics and spread of PJ.2.1 and assessed the effectiveness of antibodies generated by booster vaccines against it.

Dr. Harish Chafle, a senior consultant at Gleneagles Hospitals Parel, Mumbai, explained that PJ.2.1 is a novel saltation variant due to its extensive mutations in the spike protein. This allows it to better attach to human cells and potentially evade some pre-existing immunity. Symptoms of PJ.2.1 are similar to those of a common cold or seasonal flu, making it difficult to distinguish from other illnesses based on symptoms alone. Testing is recommended for accurate diagnosis.

While PJ.2.1 spreads more rapidly than previous variants, it does not appear to be substantially better at causing severe disease or hospitalizations. However, further real-world data is needed to establish its clinical behavior. Dr. Amit Saraf, director of internal medicine at Jupiter Hospital Thane, advised that while there is no evidence of more severe outcomes, the faster spread warrants continued vigilance.

To protect oneself from PJ.2.1 and other respiratory viruses, individuals should wear masks in crowded places, test if symptoms persist for more than two days, isolate if necessary, and consult a healthcare professional if experiencing fever, persistent cough, sore throat, or difficulty breathing. High-risk groups, such as older adults and those with underlying health conditions, should be particularly cautious.

Maintaining good hygiene practices, such as washing hands frequently, improving indoor ventilation, and staying informed, are essential precautions for everyone.